Suppressor T Cell Growth and Differentiation. Identification of a Cofactor Required for Suppressor T Cell Function and Distinct from Interleukin 2
Overview
General Medicine
Authors
Affiliations
This report describes a Ts costimulator assay and its use to analyze cofactors required for the expression of suppressor T cell function. Activation of primed MLR-Ts (alloantigen-activated suppressor T cells suppressive of mixed leukocyte reaction) to suppressor T cell factor (TsF) production typically fails in the presence of glutaraldehyde-fixed rather than irradiated allogeneic stimulator cells. However, MLR-TsF production was restored by the addition of 48-h primary MLR supernates; MLR-derived Ts costimulator neither activated primed MLR-Ts in the absence of fixed allogeneic stimulators nor directly suppressed assay MLR. Lack of antigen specificity or genetic restriction and failure to activate unprimed MLR-Ts precursors suggested that Ts costimulator activity differed from previously described Ts inducer functions and was more closely aligned with the lymphocyte- or monocyte-derived interleukins (IL). Three findings distinguished Ts costimulator from IL-2. Depletion of IL-2 activity from MLR supernates by HT2 adsorption failed to affect Ts costimulator function. In addition, MLR supernates prepared in the presence of cyclosporin A contained no IL-2 but expressed Ts costimulator activity. Finally, gel chromatography demonstrated Ts costimulator in peaks of 21,000 and 43,000 mol wt that were largely distinct from the IL-2-containing fractions. Ts costimulator activity was also identified in phorbol myristate acetate (PMA)-induced EL4 supernates and was retained in those supernates after IL-2 depletion by HT2 adsorption. In preliminary functional characterization, MLR supernate-derived Ts costimulator triggered MLR-TsF production from irradiated MLR-Ts in the absence of proliferation. Thus a differentiative rather than proliferative stimulus required for primed MLR-Ts function appears to be provided by this Ts costimulator and has been provisionally termed Ts differentiative factor ( TsDF ). This initial characterization may thus identify one of a possibly distinctive family of interleukins required in the alloantigen-driven activation of suppressor T cells to effector function.
Effect of murine interferon alpha/beta on tumour-induced suppressor function.
Sahasrabudhe D, Dusel J Cancer Immunol Immunother. 1994; 39(6):360-6.
PMID: 8001023 PMC: 11038840. DOI: 10.1007/BF01534422.
The influence of cyclosporin A on cell-mediated immunity.
Thomson A, Webster L Clin Exp Immunol. 1988; 71(3):369-76.
PMID: 2968199 PMC: 1541682.
Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.
Ebihara T, Koyama S, Fukao K, Osuga T Cancer Immunol Immunother. 1989; 28(3):218-24.
PMID: 2522349 PMC: 11038667. DOI: 10.1007/BF00204992.
Koyama S, Ebihara T, Fukao K, Osuga T Jpn J Cancer Res. 1989; 80(2):150-7.
PMID: 2498249 PMC: 5917700. DOI: 10.1111/j.1349-7006.1989.tb02283.x.
Oliveira D, Mitchison N Clin Exp Immunol. 1989; 75(2):167-77.
PMID: 2467772 PMC: 1542112.